Signal transduction via guanine nucleotide binding proteins (G proteins) is crucial in regulation of cardiovascular, neural, endocrine, and immune cell function as well as in cell growth and differentiation. It has been increasingly recognized that knowledge of the dynamic aspects of signal transduction is important to a full description of signaling mechanisms. This is most evident in the function of the novel family of C protein regulators (RGS proteins). They have been recognized only in the last few years but appear to be responsible for subsecond temporal responses of C protein regulated ion channels and for modulation of slower classical signal transduction pathways. While much in vitro biochemical information is available for RGS proteins, much less is known about their in vivo functions or their potential as targets of drug design. The three aims of this project will: 1) explore mechanisms and specificity of RGS proteins using biochemical and spectroscopic approaches, 2) test via a gene targeting approach the role of RGS proteins in the physiological actions of Gi family G proteins such as regulation of cardiac automaticity and opiate analgesia, tolerance, and dependence, and 3) examine the role and specificity of individual endogenous RGS proteins by use of ribozyme knock-down methods. The studies in this proposal should permit a better understanding of rapid G protein activation and deactivation mechanisms and will explore the potential of RGS proteins as a novel target of drug action.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM039561-16
Application #
6709340
Study Section
Pharmacology A Study Section (PHRA)
Program Officer
Lograsso, Philip
Project Start
1988-12-01
Project End
2006-02-28
Budget Start
2004-03-01
Budget End
2005-02-28
Support Year
16
Fiscal Year
2004
Total Cost
$562,031
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Pharmacology
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Rorabaugh, Boyd R; Chakravarti, Bandana; Mabe, Nathaniel W et al. (2017) Regulator of G Protein Signaling 6 Protects the Heart from Ischemic Injury. J Pharmacol Exp Ther 360:409-416
Feng, Huijie; Sjögren, Benita; Karaj, Behirda et al. (2017) Movement disorder in GNAO1 encephalopathy associated with gain-of-function mutations. Neurology 89:762-770
Sjögren, Benita; Parra, Sergio; Atkins, Kevin B et al. (2016) Digoxin-Mediated Upregulation of RGS2 Protein Protects against Cardiac Injury. J Pharmacol Exp Ther 357:311-9
Evelyn, Chris R; Lisabeth, Erika M; Wade, Susan M et al. (2016) Small-Molecule Inhibition of Rho/MKL/SRF Transcription in Prostate Cancer Cells: Modulation of Cell Cycle, ER Stress, and Metastasis Gene Networks. Microarrays (Basel) 5:
Blazer, Levi L; Storaska, Andrew J; Jutkiewicz, Emily M et al. (2015) Selectivity and anti-Parkinson's potential of thiadiazolidinone RGS4 inhibitors. ACS Chem Neurosci 6:911-9
Parra, Sergio; Huang, Xinyan; Charbeneau, Raelene A et al. (2014) Conditional disruption of interactions between G?i2 and regulator of G protein signaling (RGS) proteins protects the heart from ischemic injury. BMC Pharmacol Toxicol 15:29
Lamberts, Jennifer T; Smith, Chelsea E; Li, Ming-Hua et al. (2013) Differential control of opioid antinociception to thermal stimuli in a knock-in mouse expressing regulator of G-protein signaling-insensitive G?o protein. J Neurosci 33:4369-77
Kaur, Kuljeet; Parra, Sergio; Chen, Rong et al. (2012) G?i2 signaling: friend or foe in cardiac injury and heart failure? Naunyn Schmiedebergs Arch Pharmacol 385:443-53
Waterson, Rachael E; Thompson, Corbin G; Mabe, Nathaniel W et al. (2011) G?(i2)-mediated protection from ischaemic injury is modulated by endogenous RGS proteins in the mouse heart. Cardiovasc Res 91:45-52
Sjogren, Benita; Neubig, Richard R (2010) Thinking outside of the ""RGS box"": new approaches to therapeutic targeting of regulators of G protein signaling. Mol Pharmacol 78:550-7

Showing the most recent 10 out of 29 publications